Phloronol Inc. Report issue

For profit Phase 1
Founded: San Francisco CA United States (2010)
Status: Defunct (2021)

Organization Overview

First Clinical Trial
2013
NCT04335045
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Phloronol Inc.

Active Ingredients

Drugs in Phase 1 Trials (1)

testosterone (delatestryl) (1 trial)

Indications

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1